Case number 2021-2024
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 27, 2022 | 58 | The petition for writ of certiorari, No. 21-1458, filed on 05/16/2022, was Denied on 06/27/2022. [859062] [MVH] [Entered: 07/05/2022 02:00 PM] (1) |
| May 18, 2022 | 57 | Petition for writ of certiorari filed on 05/16/2022 in the U.S. Supreme Court. No.: 21-1458, EPA Drug Initiative II v. Hikma Pharmaceuticals International Limited. [850783] [MVH] [Entered: 05/19/2022 04:09 PM] (1) |
| Mar 24, 2022 | 56 | Mandate issued to the United States District Court for the District of Nevada. Service as of this date by the Clerk of Court. [838831] [JCP] [Entered: 03/24/2022 12:17 PM] (1) |
| Feb 20, 2022 | 0 | AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 15, 2022 | 55 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [831126] [MVH] [Entered: 02/15/2022 09:36 AM] (2) |
| Feb 11, 2022 | 54 | Submitted after ORAL ARGUMENT to Panel: Newman, Circuit Judge; Dyk, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: Mr. Michael S. Kasanoff, I for EPADI II and Mr. James Barabas for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd..Oral Argument Audio available here. [830666] [MJL] [Entered: 02/11/2022 01:28 PM] (0) |
| Jan 28, 2022 | 53 | Clerk's letter to Appellant EPADI II and Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited regarding Video Argument Orientation. Service as of this date by the Clerk of Court. [827774] [JCP] [Entered: 01/28/2022 04:10 PM] (0) |
| Jan 18, 2022 | 52 | ORDER. The court will conduct argument in this case by video at the originally scheduled date and time in lieu of in-person appearance. See order for further details. Service as of this date by the Clerk of Court. [825088] [JCP] [Entered: 01/18/2022 03:19 PM] (2) |
| Jan 4, 2022 | 51 | Corrected Response to notice of oral argument from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. Service: 01/04/2022 by email. [822513] [21-2024] [James Barabas] [Entered: 01/04/2022 11:35 AM] (3) |
| Jan 4, 2022 | 50 | Notice to Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited: The record of this case indicates that no Response to Notice of Oral Argument under FCR 34(e) has been filed. Please file the Response to Notice of Oral Argument by 01/05/22. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [822456] [MVH] [Entered: 01/04/2022 09:05 AM] (0) |
| Dec 31, 2021 | 49 | Response to notice of oral argument from Appellant EPADI II. Service: 12/31/2021 by email. [822144] [21-2024] [Michael Kasanoff] [Entered: 12/31/2021 06:28 PM] (3) |
| Dec 31, 2021 | 48 | Response to notice of oral argument from Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 12/31/2021 by email. [822127] [21-2024] [James Barabas] [Entered: 12/31/2021 10:52 AM] (3) |
| Dec 22, 2021 | 47 | Counsel are advised that the Federal Circuit has issued Revised Protocols for In-Person Arguments. All arguing counsel must file the revised Form 33A with the Response to Notice of Oral Argument by the previously set deadline. [820564] [JCP] [Entered: 12/22/2021 12:00 PM] (0) |
| Dec 17, 2021 | 46 | 6 paper copies of Doc. No. [29], [23] received from Appellant EPADI II. [819881] [VDW] [Entered: 12/20/2021 02:06 PM] (0) |
| Dec 17, 2021 | 45 | NOTICE OF ORAL ARGUMENT. Panel: 2202I. Case scheduled February 11, 2022. Response to Notice of Oral Argument due: 01/03/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [819624] [MVH] [Entered: 12/17/2021 04:00 PM] (2) |
| Dec 10, 2021 | 44 | NOTICE OF NON-COMPLIANCE: The opening brief and reply brief paper copies (Doc. No. [43]) provided by EPADI II are not in compliance with the rules of this court (see attached). Corrected paper copies are due within 5 business days. Service as of this date by the Clerk of Court. [817867] [MJL] [Entered: 12/10/2021 03:54 PM] (1) |
| Dec 9, 2021 | 42 | The following conflict dates submitted by Constance S. Huttner for Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited, Dr. Reddy's Laboratories, Inc., and Dr. Reddy's Laboratories, Ltd. have been accepted by the court: 07/05/2022, 07/06/2022, 07/07/2022, 07/08/2022. [817352] [MJL] [Entered: 12/09/2021 08:33 AM] (0) |
| Dec 8, 2021 | 41 | The following conflict dates submitted by Michael S. Kasanoff, I for EPADI II have been accepted by the court: 04/04/2022, 04/05/2022, 04/06/2022, 04/07/2022, 04/08/2022. [817225] [MJL] [Entered: 12/08/2021 04:15 PM] (0) |
| Dec 7, 2021 | 43 | 6 paper copies of Doc. No. [31], [27], [21] received from Appellant EPADI II. [817412]. The paper copies of the opening brief and reply brief are non-compliant. See Doc. No. [44]. [VDW] [Entered: 12/09/2021 10:30 AM] (0) |
| Dec 6, 2021 | 40 | Notice from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited regarding conflicts with oral argument. Service: 12/06/2021 by email. [816539] [21-2024] [Beth Finkelstein] [Entered: 12/06/2021 04:02 PM] (3) |
| Dec 1, 2021 | 39 | 6 paper copies of Doc. No. [24] received from Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. [816039] [VDW] [Entered: 12/03/2021 09:24 AM] (0) |
| Nov 30, 2021 | 38 | Notice from Appellant EPADI II regarding conflicts with oral argument. Service: 11/30/2021 by email. [815323] [21-2024] [Michael Kasanoff] [Entered: 11/30/2021 12:30 PM] (4) |
| Nov 29, 2021 | 37 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [815149] [MMA] [Entered: 11/29/2021 04:49 PM] (1) |
| Nov 29, 2021 | 36 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [815146] [MMA] [Entered: 11/29/2021 04:46 PM] (0) |
| Nov 9, 2021 | 35 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellant EPADI II. Service: 11/09/2021 by email. [811376] [21-2024] [Michael Kasanoff] [Entered: 11/09/2021 10:44 PM] (2) |
| Nov 9, 2021 | 34 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited and West-Ward Pharmaceuticals International Limited. Service: 11/09/2021 by email. [811358] [21-2024] [Charles Klein] [Entered: 11/09/2021 06:04 PM] (2) |
| Nov 9, 2021 | 33 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 11/09/2021 by email. [811352] [21-2024] [Beth Finkelstein] [Entered: 11/09/2021 05:22 PM] (2) |
| Nov 9, 2021 | 32 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant EPADI II. Service: 11/09/2021 by email. [811348] [21-2024] [Michael Kasanoff] [Entered: 11/09/2021 05:01 PM] (4) |
| Nov 4, 2021 | 28 | NOTICE OF NON-COMPLIANCE: The submission of Appellant EPADI II, Corrected Reply Brief, Appendix [27], [26], is not in compliance with the rules of this court (see attached). Compliant document due on 11/12/2021. Service as of this date by the Clerk of Court. [810173] [JCW] [Entered: 11/04/2021 10:58 AM] (1) |
| Nov 4, 2021 | 29 | MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED by Appellant EPADI II. Service: 11/04/2021 by email. [810324]--[Edited 11/29/2021 by MMA - Reason: compliance review complete] [Michael Kasanoff] [Entered: 11/04/2021 04:35 PM] (44) |
| Nov 4, 2021 | 30 | Notice of Correction to Doc No. [29] for Appellant EPADI II. Service: 11/04/2021 by email. [810326] [21-2024] [Michael Kasanoff] [Entered: 11/04/2021 04:37 PM] (3) |
| Nov 4, 2021 | 31 | MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant EPADI II. Service: 11/04/2021 by email. [810328]--[Edited 11/29/2021 by MMA - Reason: compliance review complete] [Michael Kasanoff] [Entered: 11/04/2021 04:47 PM] (412) |
| Nov 3, 2021 | 27 | CORRECTED REPLY BRIEF FILED by Appellant EPADI II. Service: 11/03/2021 by email. [809937] [21-2024] This document is non-compliant. See Doc No.[28] [Michael Kasanoff] [Entered: 11/03/2021 12:54 PM] (44) |
| Nov 2, 2021 | 26 | APPENDIX FILED by Appellant EPADI II. Service: 11/02/2021 by email. [809839] [21-2024] This document is non-compliant. See Doc No.[28] [Michael Kasanoff] [Entered: 11/02/2021 11:54 PM] (438) |
| Nov 2, 2021 | 25 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant EPADI II. Service: 11/02/2021 by email. [809837] --[Edited 11/04/2021 by JCW] This document has been corrected. See Doc. No. [29] [Michael Kasanoff] [Entered: 11/02/2021 11:48 PM] (44) |
| Oct 12, 2021 | 24 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. Service: 10/12/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [804956] --[Edited 10/18/2021 by JCW - compliance review complete] [Constance Huttner] [Entered: 10/12/2021 01:47 PM] (55) |
| Sep 13, 2021 | 23 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellant EPADI II. Service: 09/13/2021 by email. [798944]--[Edited 09/14/2021 by JCW - compliance review complete] [Michael Kasanoff] [Entered: 09/13/2021 10:40 PM] (227) |
| Sep 13, 2021 | 22 | NOTICE OF NON-COMPLIANCE: The submission of Appellant EPADI II, Corrected Opening Brief [21], is not in compliance with the rules of this court (see attached). Compliant document due on 09/20/2021. Service as of this date by the Clerk of Court. [798866] [JCW] [Entered: 09/13/2021 03:54 PM] (1) |
| Sep 4, 2021 | 21 | CORRECTED OPENING BRIEF FILED by Appellant EPADI II. Service: 09/04/2021 by email. [797338] [21-2024] This document is non-compliant. See Doc No.[22] [Michael Kasanoff] [Entered: 09/04/2021 01:35 AM] (227) |
| Sep 3, 2021 | 20 | NOTICE OF NON-COMPLIANCE: The submission of Appellant EPADI II, Corrected Opening Brief [19], is not in compliance with the rules of this court (see attached). Compliant document due on 09/13/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [797104] [JCW] [Entered: 09/03/2021 11:02 AM] (2) |
| Sep 2, 2021 | 19 | CORRECTED OPENING BRIEF FILED by Appellant EPADI II. Service: 09/02/2021 by email. [796795] [21-2024] This document is non-compliant. See Doc No. [20] [Michael Kasanoff] [Entered: 09/02/2021 12:32 AM] (227) |
| Sep 2, 2021 | 18 | Amended Certificate of Interest for Appellant EPADI II. Service: 09/02/2021 by email. [796794] [21-2024] [Michael Kasanoff] [Entered: 09/02/2021 12:29 AM] (3) |
| Sep 1, 2021 | 17 | NOTICE OF NON-COMPLIANCE: The submission of Appellant EPADI II, Opening Brief [16], is not in compliance with the rules of this court (see attached). Compliant document due on 09/09/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [796628] [JCW] [Entered: 09/01/2021 02:11 PM] (1) |
| Aug 31, 2021 | 16 | OPENING BRIEF FILED by Appellant EPADI II. Service: 08/31/2021 by email. [796214] [21-2024] This document is non-compliant. See Doc No. [17] [Michael Kasanoff] [Entered: 08/31/2021 09:35 AM] (227) |
| Aug 16, 2021 | 15 | ORDER filed denying [13] motion filed by EPADI II. Appellant's opening brief is due 09/27/2021. Service as of this date by the Clerk of Court. [792923] [NL] [Entered: 08/16/2021 02:57 PM] (2) |
| Jul 28, 2021 | 14 | ORDER staying the briefing schedule pending consideration of the motion. Service as of this date by the Clerk of Court. [789111] [LMS] [Entered: 07/28/2021 10:08 AM] (2) |
| Jul 20, 2021 | 13 | MOTION of Appellant EPADI II Leave to Rely Upon the Appendix Previously Submitted. Service: 07/20/2021 by email. [787296] [21-2024] [Michael Kasanoff] [Entered: 07/20/2021 11:28 AM] (3) |
| Jun 22, 2021 | 12 | Certificate of Interest for Amarin Pharma, Inc.; Amarin Pharmaceuticals Ireland Limited. Service: 06/22/2021 by email. [781857] [21-2024] [Christopher Sipes] [Entered: 06/22/2021 06:19 PM] (4) |
| Jun 22, 2021 | 11 | Entry of appearance for Christopher N. Sipes; Jeffrey B. Elikan; Eric Ritland Sonnenschein as counsel for Amarin Pharma, Inc.; Amarin Pharmaceuticals Ireland Limited. Service: 06/22/2021 by email. [781856] [21-2024] [Christopher Sipes] [Entered: 06/22/2021 06:16 PM] (2) |
| Jun 22, 2021 | 10 | Certificate of Interest for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 06/22/2021 by email. [781854] [21-2024] [Constance Huttner] [Entered: 06/22/2021 05:50 PM] (3) |
| Jun 22, 2021 | 9 | Docketing Statement for the Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 06/22/2021 by email. [781853] [21-2024] [Constance Huttner] [Entered: 06/22/2021 05:49 PM] (2) |
| Jun 22, 2021 | 8 | Entry of appearance for Constance S. Huttner; James P. Barabas; Caroline Sun; Beth Finkelstein as counsel for Appellees Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.. Service: 06/22/2021 by email. [781852] [21-2024] [Constance Huttner] [Entered: 06/22/2021 05:47 PM] (2) |
| Jun 22, 2021 | 7 | Certificate of Interest for Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. Service: 06/22/2021 by email. [781764] [21-2024] [Charles Klein] [Entered: 06/22/2021 02:24 PM] (3) |
| Jun 22, 2021 | 6 | Docketing Statement for the Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. Service: 06/22/2021 by email. [781760] [21-2024] [Charles Klein] [Entered: 06/22/2021 02:18 PM] (3) |
| Jun 22, 2021 | 5 | Entry of appearance for Charles B. Klein; Eimeric Reig-Plessis; Claire A. Fundakowski; Alison M. King as counsel for Appellees Hikma Pharmaceuticals International Limited, Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited. Service: 06/22/2021 by email. [781757] [21-2024] [Charles Klein] [Entered: 06/22/2021 02:11 PM] (2) |
| Jun 21, 2021 | 4 | Docketing Statement for the Appellant EPADI II. Service: 06/21/2021 by email. [781187] [21-2024] [Michael Kasanoff] [Entered: 06/21/2021 08:32 AM] (2) |
| Jun 21, 2021 | 3 | Certificate of Interest for Appellant EPADI II. Service: 06/21/2021 by email. [781186] [21-2024] [Michael Kasanoff] [Entered: 06/21/2021 08:31 AM] (3) |
| Jun 21, 2021 | 2 | Entry of appearance for Michael S. Kasanoff as counsel for Appellant EPADI II. Service: 06/21/2021 by email. [781185] [21-2024] [Michael Kasanoff] [Entered: 06/21/2021 08:27 AM] (1) |
| Jun 8, 2021 | 1 | Appeal docketed. Received: 05/28/2021. [779056]Entry of Appearance due 06/22/2021. Certificate of Interest is due on 06/22/2021. Docketing Statement due 06/22/2021. Appellant/Petitioner's brief is due 08/09/2021. [MMA] [Entered: 06/08/2021 02:00 PM] (97) |
